Case 1 |
Day |
0 |
First dose of coronavirus disease 2019 (COVID-19) Vaccine Moderna. Patient remained without symptoms |
36 |
Second dose of COVID-19 Vaccine Moderna |
37 |
General malaise and fatigue, later chest discomfort |
41 |
Hospital admission |
41–44 |
Intermediate care unit |
|
No heart rhythm anomalies |
|
Steady resolution of symptoms |
44 |
No symptoms |
|
Transfer to general ward |
|
Cardiac magnetic resonance imaging (MRI) confirms myocarditis |
45 and 46 |
Resolution of wall motion abnormalities and normalization of troponin-T |
|
[Admission of Case 2] |
47 |
Discharge of Patient 1 |
Case 2 |
Day |
0 |
First dose of COVID-19 Vaccine Moderna. Patient remained without symptoms |
47 |
Second dose of COVID-19 Vaccine Moderna |
48 |
Arthralgia and general malaise, fever |
49 |
Epigastric pain |
50 |
Transfer from tertiary centre and hospital admission |
51 |
Coronary angiography, coronary artery disease ruled out |
50–54 |
Intermediate care unit |
|
Heart failure therapy |
|
No heart rhythm anomalies |
|
Slow resolution of symptoms |
53 |
Cardiac MRI confirms myocarditis |
54 |
No epigastric pain |
|
Decrease of troponin-T |
|
Transfer to general ward |
56 |
No symptoms |
|
Resolution of wall motion abnormalities |
|
Discharge of Patient 2 |